Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Placebo published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 172
» View wsbtradio.com items only
    Jun 13, 2013 |Story| Reuters
  1. Scant data on seizure drugs for women's genital pain

    Reuters
    NEW YORK (Reuters Health) - Although doctors sometimes prescribe anti-seizure drugs to treat chronic pain in the vulva, just a handful of low-quality studies have examined the drugs' effects, according to a new review. Based on these studies, "it's...

    Tags: University of North Carolina at Chapel Hill, Medical Research, Trials, Pharmaceuticals, Neurontin (drug)

  2. Jun 12, 2013 |Column| Chicago Tribune
  3. Statins may reduce benefits of exercise

    Millions of people take statin drugs to lower their cholesterol. But the medications may also interfere with the positive effects of exercise in some patients, according to <a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/23583255" target="_blank">a small study </a>published in the Journal of the American College of Cardiology.
    Millions of people take statin drugs to lower their cholesterol. But the medications may also interfere with the positive effects of exercise in some patients, according to a small study published in the Journal of the American College of Cardiology....

    Tags: Medical Research, Heart Disease, Physical Fitness and Exercise, Weight, Tribune Tower

  4. Jun 12, 2013 |Story| Reuters
  5. Drugs halve HIV risk for intravenous drug users in study

    CHICAGO (Reuters) - A daily dose of powerful anti-HIV medicine helped cut the risk of infection with the&nbsp; virus by 49 percent in intravenous drug users in a Bangkok study that showed for the first time such a preventive step can work in this high-risk population.
    Reuters
    CHICAGO (Reuters) - A daily dose of powerful anti-HIV medicine helped cut the risk of infection with the  virus by 49 percent in intravenous drug users in a Bangkok study that showed for the first time such a preventive step can work in this high-risk...

    Tags: Medical Research, Substance Abuse, Methadone (drug), Pharmaceuticals, HIV Treatment

  6. Jun 12, 2013 |Story| La Cañada
  7. Thoughts from Dr. Joe: It's just a game, folks!

    I have this recurring nightmare reflective of my persnickety perspective on American sports. You know who Barabbas is? He's the villainous character in the biblical story of Christ's passion that Pontius Pilate releases instead of Jesus. Barabbas is in my...

    Tags: Starbucks Corp.

  8. Jun 11, 2013 |Story| Los Angeles Times
  9. Belviq, the new miracle diet drug? Fat chance.

    A new diet drug went on the market Tuesday. It&rsquo;s expensive and has to be taken the rest of the patient&rsquo;s life to continue to work. It comes with a long list of possible side effects, including common ones such as dizziness, fatigue and constipation, or rare ones such as hallucinations or memory loss. On average, it doesn&rsquo;t have much effect on a person&rsquo;s weight.
    This post has been corrected, as indicated below.
    A new diet drug went on the market Tuesday. It’s expensive and has to be taken the rest of the patient’s life to continue to work. It comes with a long list of possible side effects, including common ones such as dizziness, fatigue and...

    Tags: Physical Fitness and Exercise, Pharmaceuticals, Meridia (drug), Weight, ABC (tv network)

  10. Jun 12, 2013 |Story| Reuters
  11. Amgen says drug slowed ovarian cancer in trial

    Reuters
    (Reuters) - Amgen Inc's trebananib drug for ovarian cancer extended the length of time that patients lived without the disease getting worse by about two months, meeting the main goal of a late-stage clinical trial, the company said on Wednesday. The...

    Tags: Amgen Inc., Biotechnology, Ovarian Cancer, Science and Technology, Trials

  12. Jun 12, 2013 |Story| Reuters
  13. AIDS drugs halve HIV risk for intravenous drug users in study

    Reuters
    * More evidence drugs can prevent HIV in high-risk groups * U.S. CDC: study is "significant step" in HIV prevention By Julie Steenhuysen CHICAGO, June 12 (Reuters) - A daily dose of powerful anti-HIV medicine helped cut the risk of infection with the...

    Tags: Medical Research, Substance Abuse, Methadone (drug), Pharmaceuticals, HIV Treatment

  14. Jun 11, 2013 |Story| Reuters
  15. Celgene arthritis drug maintains efficacy at 52 weeks-study

    Reuters
    By Bill Berkrot June 11 (Reuters) - Celgene Corp's experimental drug for psoriatic arthritis maintained its ability to significantly reduce painful symptoms through 52 weeks of treatment, according to data from a late stage study being presented this...

    Tags: Medical Research, Symptoms, Trials, Science and Technology, Psoriasis

  16. Jun 11, 2013 |Story| Reuters
  17. J&J's Stelara effective in psoriatic arthritis trial

    Reuters
    By Bill Berkrot June 11 (Reuters) - Johnson & Johnson's Stelara produced significant improvement in signs and symptoms of psoriatic arthritis through 52 weeks of treatment in a late stage study, according to data being presented at a medical meeting in...

    Tags: Medical Research, Arthritis, Science and Technology, Trials, Humira (drug)

  18. Jun 6, 2013 |Story| Los Angeles Times
  19. FDA panel recommends continued Avandia sales, with restrictions

    An advisory panel to the Food and Drug Administration on Thursday voted to keep the diabetes drug Avandia on the market with a slate of restrictions on its use, and suggested that although evidence of the drug's safety problems may have been overblown, Avandia's days as a blockbuster diabetes medication are probably behind it.
    An advisory panel to the Food and Drug Administration on Thursday voted to keep the diabetes drug Avandia on the market with a slate of restrictions on its use, and suggested that although evidence of the drug's safety problems may have been overblown,...

    Tags: Medical Research, Duke University, Trials, Science and Technology, Pharmaceuticals

  20. Jun 3, 2013 |Story| Los Angeles Times
  21. Daily sunscreen use slows signs of aging skin, study finds

    As if reducing the threat of skin cancer was not enough, scientists report that they have shown using sunscreen daily can slow the signs of aging skin -- even into middle age.
    As if reducing the threat of skin cancer was not enough, scientists report that they have shown using sunscreen daily can slow the signs of aging skin -- even into middle age. Skin ages as people age, obviously. The sun is a major culprit in the skin&...

    Tags: Medical Research, Physical Conditions, Internal Medicine, Science and Technology, Skin Cancer

  22. Jun 2, 2013 |Story| Reuters
  23. Bayer's Nexavar shown to delay thyroid cancer by 5 months

    Reuters
    FRANKFURT, June 2 (Reuters) - Bayer said on Sunday its cancer drug Nexavar was shown to delay progression of a difficult-to-treat type of thyroid cancer by about five months, as the German drugmaker seeks to widen the use of the pill. The indication,...

    Tags: Litigation, Oncology, Trials, Breast Cancer, Drugs and Medicines

 1  2 3 4 5 6 7 8 9 10 11-15Next >
Original site for Placebo topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Placebo Photos
It's not that bizarre in and of itself: studies have sh...
(February 2, 2013)
Beetroot juice
A recent study has shown that men who take 400 internat...
(October 11, 2011)
&nbsp;